Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04798079 · ClinicalTrials.gov registry record
Systems Biology of Early Atopy
A clinical trial of Atopic Dermatitis and Food Allergy, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Active
- Registry status
- 2,500
- Enrollment target
- 13
- Study locations
NCT04798079 is a study of Atopic Dermatitis and Food Allergy that is active but no longer recruiting, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 2,500 participants, above the 593-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (322% higher). The trial reports 13 study locations across 13 states.
The verdict
NCT04798079, a study of Atopic Dermatitis and Food Allergy, is active but no longer recruiting, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- ACTIVE NOT RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 13
- Study locations
Study Summary
The goal of this study is to establish a birth cohort that collects prenatal and early life biosamples and environmental samples and rigorously phenotypes young children for food allergy and Atopic Dermatitis (AD) to identify prenatal and early life markers of high risk for food allergy and AD, as well as biological pathways (endotypes) that result in these conditions. Primary Objectives: * To study the role and interrelationships of established and novel clinical, environmental, biological, and genetic prenatal and early-life factors in the development and course of allergic diseases through age 3 years (or 6 years for those who choose to continue participation into SUNBEAM II), with an emphasis on atopic dermatitis and food allergy * To apply systems biology to identify mechanisms and biomarkers underlying the development of food allergy, atopic dermatitis, and their endotypes * To collect, process, and assay or store environmental and biological samples for current and future use in the study of allergic disease development
Conditions Studied
Study Locations (13)
Arkansas
- Arkansas Children's Hospital - Little Rock
California
- Sean N. Parker Center for Allergy & Asthma Research at Stanford University - Stanford
Colorado
- National Jewish Health - Denver
Illinois
- Northwestern University Feinberg School of Medicine: Dept of Dermatology - Chicago
Maryland
- Johns Hopkins Children's Center, Department of Allergy & Immunology - Baltimore
Massachusetts
- Massachusetts General Hospital, Translational and Clinical Research Center - Boston
Michigan
- Henry Ford Health System, Division of Allergy and Immunology - Detroit
New York
- Kravis Children's Hospital, Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2021-03-18 |
| Est. Completion | 2032-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04798079
The ClinicalTrials.gov registry entry for NCT04798079 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 593-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (322% higher). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Atopic Dermatitis appearing as the primary indexed condition, and to 0 interventions.
NCT04798079 reports 13 study locations spanning 13 distinct geographic areas - top geographies include Arkansas, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT04798079 about?
NCT04798079 is a clinical study titled "Systems Biology of Early Atopy". The goal of this study is to establish a birth cohort that collects prenatal and early life biosamples and environmental samples and rigorously phenotypes young children for food allergy and Atopic Dermatitis (AD) to identify prenatal and early life markers of high risk for food allergy and AD, as w...
What is the current status of trial NCT04798079?
This trial is currently active not recruiting. The enrollment target is 2,500 participants. The study started on 2021-03-18. Estimated completion is 2032-03.
What conditions does trial NCT04798079 study?
This clinical trial studies the following conditions: Atopic Dermatitis, Food Allergy, Allergic Diseases.
Who is sponsoring clinical trial NCT04798079?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04798079 being conducted?
This trial has 13 study locations across Arkansas, California, Colorado, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atopic Dermatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry for Systemic Eczema Treatments
RECRUITING
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
RECRUITING
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RECRUITING · Phase 2
-
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
RECRUITING · Phase 1
-
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.